Original language | English (US) |
---|---|
Number of pages | 1 |
Journal | Breast Cancer Research and Treatment |
Volume | 155 |
Issue number | 3 |
DOIs |
|
State | Published - Feb 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Oncology
- Cancer Research
Cite this
Erratum to : Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4). / Pessetto, Ziyan Yuan; Yan, Ying; Bessho, Tadayoshi; Natarajan, Amarnath.
In: Breast Cancer Research and Treatment, Vol. 155, No. 3, 01.02.2016.Research output: Contribution to journal › Comment/debate
}
TY - JOUR
T1 - Erratum to
T2 - Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)
AU - Pessetto, Ziyan Yuan
AU - Yan, Ying
AU - Bessho, Tadayoshi
AU - Natarajan, Amarnath
PY - 2016/2/1
Y1 - 2016/2/1
UR - http://www.scopus.com/inward/record.url?scp=84959116168&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959116168&partnerID=8YFLogxK
U2 - 10.1007/s10549-016-3702-6
DO - 10.1007/s10549-016-3702-6
M3 - Comment/debate
C2 - 26883325
AN - SCOPUS:84959116168
VL - 155
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
SN - 0167-6806
IS - 3
ER -